Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

LL-37 Results After 1 Month: Mechanism Comparison

Direct antimicrobial activity 6–48 hours CFU reduction of 90–99% in bacterial cultures; fungal growth inhibition CFU plating, MIC assays This is the fastest LL-37 mechanism. Membrane disruption is immediate and doesn't require downstream signalling Pro-inflamm

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Direct antimicrobial activity
  • 6–48 hours
  • CFU reduction of 90–99% in bacterial cultures; fungal growth inhibition
  • CFU plating, MIC assays
  • This is the fastest LL-37 mechanism. Membrane disruption is immediate and doesn't require downstream signalling
  • Pro-inflammatory cytokine suppression
  • 7–12 days
  • IL-6 reduced by 40–60%; TNF-alpha reduced by 30–50% vs baseline
  • ELISA, multiplex cytokine panels
  • Cytokine reductions stabilise by week 3. Earlier measurements may miss the full effect
  • Wound closure and re-epithelialisation
  • 14–28 days
  • 50–60% faster wound closure in impaired healing models; increased keratinocyte migration
  • Planimetry, histological sectioning
  • Visible tissue changes lag behind biochemical shifts. This is a structural remodeling process, not just inflammation control
  • Regulatory T-cell expansion
  • 20–35% increase in CD4+CD25+FoxP3+ Treg frequency
  • Flow cytometry
  • Treg expansion is one of the slowest LL-37 effects but may be the most durable. Systemic immune balance shifts require sustained signalling
  • Chemotaxis and immune cell recruitment
  • 3–10 days
  • Peak neutrophil and monocyte infiltration at infection/injury sites
  • Immunohistochemistry, cell tracking
  • Immune cell recruitment happens before visible healing. This is the bridge between immediate antimicrobial action and delayed tissue repair